Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012;7(5):e38361.
doi: 10.1371/journal.pone.0038361. Epub 2012 May 30.

BRCA2 mutations and triple-negative breast cancer

Peter Meyer  1 , Katharina Landgraf, Bernhard Högel, Wolfgang Eiermann, Beyhan Ataseven
Affiliations

BRCA2 mutations and triple-negative breast cancer

Peter Meyer et al. PLoS One. 2012.

Abstract

Recently, BRCA1 germline mutations were found in a high proportion (14-34%) of patients with triple-negative breast cancer (TNBC). BRCA2 was either not analyzed or showed much lower mutation frequencies. Therefore, we screened a group of TNBC patients (n = 30) of white European descent for mutations in BRCA2 as well as in BRCA1. Cases were unselected for age of disease-onset (median age at breast cancer diagnosis was 58 years, ranging from 37 to 74 years), family history of cancer and BRCA1 and BRCA2 mutation status. Half of the patients (15/30) showed a family history of breast and/or ovarian cancer. A high frequency of deleterious germline mutations was observed in BRCA2 (5/30; 16.7%), and only one case showed a BRCA1 mutation (3.3%). Although the study group was small, these results point to BRCA2 mutations being important in TNBC.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

References

    1. Foulkes WD, Smith IE, Reis-Filho JS. 20. N. Engl. J. Med 363; 2010. Triple-negative breast cancer. pp. 1938–1948. - PubMed
    1. Young SR, Pilarski RT, Donenberg T, Shapiro C, Hammond LS et al. The prevalence of BRCA1 mutations among young women with triple-negative breast cancer. BMC Cancer. 2009;9:86. - PMC - PubMed
    1. Evans DG, Howell A, Ward D, Lalloo F, Jones JL et al. 8. J. Med. Genet 48; 2011. Prevalence of BRCA1 and BRCA2 mutations in triple negative breast cancer. pp. 520–522. - PubMed
    1. Gonzalez-Angulo AM, Timms KM, Liu S, Chen H, Litton JK et al. 5. Clin. Cancer Res 17; 2011. Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer. pp. 1082–1089. - PMC - PubMed
    1. Comen E, Davids M, Kirchhoff T, Hudis C, Offit K et al. 1. Breast Cancer Res. Treat 129; 2011. Relative contributions of BRCA1 and BRCA2 mutations to “triple-negative” breast cancer in Ashkenazi Women. pp. 185–190. - PMC - PubMed

Publication types